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The transcriptional coactivator PGC-1 is a key regulator of energy metabolism, yet little is known about its
role in control of substrate selection. We found that physiological stimuli known to induce PGC-1 expression
in skeletal muscle coordinately upregulate the expression of pyruvate dehydrogenase kinase 4 (PDK4), a
negative regulator of glucose oxidation. Forced expression of PGC-1 in C2C12 myotubes induced PDK4 mRNA
and protein expression. PGC-1-mediated activation of PDK4 expression was shown to occur at the transcrip-
tional level and was mapped to a putative nuclear receptor binding site. Gel shift assays demonstrated that the
PGC-1-responsive element bound the estrogen-related receptor  (ERR), a recently identified component of
the PGC-1 signaling pathway. In addition, PGC-1 was shown to activate ERR expression. Chromatin
immunoprecipitation assays confirmed that PGC-1 and ERR occupied the mPDK4 promoter in C2C12
myotubes. Additionally, transfection studies using ERR-null primary fibroblasts demonstrated that ERR is
required for PGC-1-mediated activation of the mPDK4 promoter. As predicted by the effects of PGC-1 on
PDK4 gene transcription, overexpression of PGC-1 in C2C12 myotubes decreased glucose oxidation rates.
These results identify the PDK4 gene as a new PGC-1/ERR target and suggest a mechanism whereby
PGC-1 exerts reciprocal inhibitory influences on glucose catabolism while increasing alternate mitochondrial
oxidative pathways in skeletal muscle.
The transcriptional coactivator peroxisome proliferator-ac-
tivated receptor  (PPAR) coactivator 1 (PGC-1) is a key
regulator of cellular energy metabolism (40), having known
roles in thermogenesis (41), mitochondrial biogenesis (28, 56),
fatty acid oxidation (51), and hepatic gluconeogenesis (14, 57).
PGC-1 is enriched in metabolically active tissues including
brown adipose tissue, the heart, and slow-twitch skeletal mus-
cles (30, 41). In contrast to most transcriptional coactivators,
expression of the PGC-1 gene is highly inducible in accor-
dance with tissue-specific energy demands. For example,
PGC-1 expression is rapidly increased in brown adipose tissue
following cold exposure (41), in the liver and heart following
short-term starvation (28, 57), in skeletal muscle with exercise
(2, 12, 38), and in the postnatal heart coincident with an in-
crease in mitochondrial fatty acid oxidation (28). Gain-of-func-
tion and loss-of-function studies have demonstrated that
PGC-1 is necessary and sufficient to increase mitochondrial
content and respiratory capacity in response to physiological
stimuli in adipocytes (31, 41), skeletal muscle (29, 56), and the
heart (1, 29, 44, 54). Skeletal-muscle-specific overexpression of
PGC-1 results in a fiber type switch from fast-twitch (type II)
to slow-twitch (type I) oxidative fibers (30). Slow-twitch fibers
are characterized by increased insulin sensitivity, mitochon-
drial mass, and oxidative capacity. Recent studies have also
demonstrated altered expression of PGC-1 in diabetic skele-
tal muscles (36) and hearts (8).
A variety of transcription factors are known to be coacti-
vated by PGC-1, including PPAR (41), PPAR (51),
FOXO1 (39), and estrogen-related receptor  (ERR) (18,
46). In brown adipose tissue, PGC-1 interacts with PPAR
and other transcription factors to regulate the expression of
genes involved in adaptive thermogenesis (41). The PGC-1/
PPAR pathway is involved in the regulation of mitochondrial
fatty acid oxidation genes in the heart (28, 51). The PGC-1/
FOXO1 pathway activates expression of gluconeogenic genes
in the liver (39). More recently, the PGC-1/ERR pathway
has been shown to play a role in regulating both fatty acid
oxidation and mitochondrial genes in heart and skeletal muscle
(20, 35, 45, 53).
In contrast to the role of PGC-1 in the regulation of fatty
acid oxidation, mitochondrial respiratory function, and hepatic
gluconeogenesis, its function as a potential regulator of glucose
utilization pathways has not been well defined. Indeed, the few
reports relating PGC-1 to glucose uptake are conflicting.
PGC-1 has been reported to induce (33) or repress (34)
expression of the glucose transporter GLUT4. Given that reg-
ulatory mechanisms exist for reciprocal control of fatty acid
and glucose oxidation, it is likely that the PGC-1 regulatory
circuit directly or indirectly influences both pathways. Cellular
glucose utilization is tightly regulated at multiple levels, includ-
ing uptake by the glucose transporters (e.g., GLUT4), glyco-
lytic flux, and entry of pyruvate into the citric acid cycle via the
pyruvate dehydrogenase complex (PDC). In muscle, the PDC
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serves a critical, rate-limiting step in the regulation of the
glucose oxidation pathway by catalyzing the irreversible decar-
boxylation of pyruvate to acetyl coenzyme A. A significant
body of evidence indicates that multiple regulatory pathways
converge on the PDC, including allosteric regulation interme-
diates of fatty acid oxidation and posttranslational control by a
family of pyruvate dehydrogenase kinases (PDK1 to -4) and
corresponding phosphatases (reviewed in references 13 and
16). The reversible phosphorylation of the PDC inactivates this
complex, sparing glucose and favoring fatty acid oxidation.
PDK4 has proven to be particularly important in the muscle
and liver response to fasting and exercise (15, 37, 54). PDK4
activity and expression are increased in diabetes concurrent
with reduced capacity for muscle and hepatic glucose oxida-
tion. Interestingly, PGC-1 is also activated by fasting and
exercise. In addition, recent studies have shown that activators
of PPAR, a known PGC-1 target, induce the expression of
PDK4 (17, 55). However, the mechanism whereby PPAR
regulates PDK4 gene expression has not been delineated. Re-
cent studies have also shown that the forkhead transcription
factor FOXO1 and the glucocorticoid receptor (GR), two
additional potential PGC-1 partners, directly regulate PDK4
expression through consensus binding sites in the PDK4 gene
promoter (9, 26).
The present study was designed to investigate the poten-
tial regulatory influence of the inducible transcriptional co-
FIG. 1. Activation of PDK4 gene expression by physiological stimuli and by overexpression of PGC-1. (A) Northern blot studies performed
with 15 g of total RNA isolated from the gastrocnemii of animals following two bouts of exercise as described in Materials and Methods (Ex)
or from sedentary controls (C) (n  4). Blots were sequentially hybridized with probes specific for the genes encoding PGC-1 and PDK4.
Representative autoradiographs are shown at the top. Phosphorimage-based quantification of Northern blot signal intensities is shown in the
graph. Data represent mean arbitrary units (SE) normalized to sedentary control values (taken as 1.0). (B) Results of Northern blot analysis
performed as described above on gastrocnemius samples immediately following 6 h of cold exposure (Cold) and from room temperature controls
(C) (n  6). Graph represents mean arbitrary units (SE) as determined by real-time PCR quantification corrected to the 36B4 transcript and
normalized to the values for control littermates (taken as 1.0). (C) RNA analysis of PGC-1 and PDK4 gastrocnemius gene expression 1 h and
3 h after a single bout of exercise (n  4). The graph represents mean arbitrary units (SE) as determined by RT-PCR corrected to the 36B4
transcript and normalized to the value for sedentary controls (taken as 1.0). (D) RNA analyses and Western blot analysis were performed with
samples isolated from Ad-GFP- or Ad–PGC-1-infected C2C12 myotubes. (Top) Results of Northern blotting performed as described above. Data
represent mean arbitrary units (SE) as determined by RT-PCR corrected to the 36B4 transcript and normalized to value for control Ad-GFP-
infected samples (taken as 1.0). (Bottom) Western blot analysis of whole-cell extracts (25 g) prepared from C2C12 myotubes infected with
adenovirus vectors expressing GFP or PGC-1. Asterisks indicate significant differences (P  0.05) from controls.
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activator PGC-1 on glucose oxidation through effects on
PDK4 gene expression. We found that PGC-1 directly
activates PDK4 gene transcription in skeletal myotubes,
leading to a reduction in glucose oxidation rates. Surpris-
ingly, the PGC-1-mediated activation of PDK4 transcrip-
tion was shown to be independent of PPAR and FOXO1;
rather, it is dependent on the muscle-enriched orphan nu-
clear receptor ERR. Collectively, these results identify a
new PGC-1 gene target and suggest a mechanism whereby
PGC-1 reciprocally downregulates glucose oxidation while
activating mitochondrial fatty acid oxidation in skeletal mus-
cle. Given the importance of PDK4-mediated regulation of
muscle glucose utilization, these results provide additional
insight into the proposed link between PGC-1 and meta-
bolic disorders such as diabetes.
MATERIALS AND METHODS
Animal studies. All animal experiments and euthanasia protocols were con-
ducted in strict accordance with the National Institutes of Health guidelines for
humane treatment of animals and were reviewed and approved by the Animal
Care Committee of Washington University. Unless stated otherwise, 6- to
8-week-old male C57BL/6J mice were used for all animal experiments. A mod-
ified treadmill protocol was used for acute exercise experiments (29). In brief,
animals were acclimated to the treadmill for 10 min, and on each of the following
2 days, animals exercised for 1 h total, alternating 2 min of running (20 m/min at
an 18° incline) with 1 min of rest. Twelve hours following the final bout of
exercise, animals were sacrificed, and gastrocnemius muscles were dissected and
snap-frozen in liquid nitrogen for RNA extraction. For time course studies,
animals underwent a single bout of running following 2 days of 10-min acclima-
tion to the treadmill. Runs were staggered so that all samples would be collected
at the same time of day (0900 h). For cold exposure experiments, animals were
maintained at 4°C for 6 h as previously described (29); immediately afterwards,
they were sacrificed and their tissues dissected for RNA extraction.
Plasmid constructs. (i) Mammalian expression vectors. pcDNA3.1-myc/
his.PGC-1, pcDNA3.1-ERR, CDM-PPAR, and CDM-RXR have been
described previously (18, 51). The expression vector pcDNA3-Flag-FKHR
(FOXO1) was provided by W. R. Sellers (Dana-Faber Cancer Institute) and has
been described previously (49).
(ii) Reporter constructs. The mouse PDK4 (mPDK4) gene promoter dele-
tion series was generated by PCR amplification from C57BL/6J genomic
DNA followed by cloning into the pGL3 Basic firefly luciferase reporter
plasmid using MluI and BglII sites (Promega, Madison, WI). The following







CACTGT-3 (mPDK4.Luc.190). The same 3 primer was used with all constructs:
5-AGATCTGAGCCTGGGTGAAGGGTTGACACTT-3. Site-directed mu-
tagenesis was performed using the QuikChange kit (Stratagene, La Jolla, CA)
according to the manufacturer’s protocol using complementary oligonucleotides as
follows (with mutated nucleotides shown in lowercase): 5-GATGGCTCTGGAGT
TGTAggggAGGACAAGTCTGGG-3 (IRSmut), 5-CTGGAGTTGTAAACAgat
ctAAGTCTGGGCGG-3 (NRmut), 5-GGAGTTGTAAACAAGGACAAGTCT
aaGCttGCCTGAAGTCCTAGCG-3 (Sp1mut), and 5-CTGGAGTTGTAAACA
AcGACAAGTCTGGGCGG-3 (NRptmut). Primers were designed, and clones
were analyzed, using Vector NTI Suite 9 (InforMax, Rockville, MD) and the re-
ported mPDK4 gene sequence (GenBank accession number NT_039340). All clones
were verified by ABI automated sequencing through the Protein and Nucleic Acid
Chemistry Laboratory (PNACL) at Washington University. Numbering was deter-
mined by estimating the transcription start site (1) by homology to the human
PDK4 (hPDK4) gene (43) (GenBank accession number NM_002612). Candidate
transcription factor response elements were identified using the Match program
(http://www.gene-regulation.com).
(iii) Adenovirus expression vectors. The adenovirus (Ad)-green fluorescent
protein (GFP), Ad–PGC-1, Ad-ERR, and Ad-PPAR expression vectors
have been described previously (18, 19, 28).
Cell culture, transient transfection, and luciferase reporter studies. C2C12
myoblasts and CV-1 cells were maintained at 37°C under 5% CO2 in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal calf serum.
For experiments requiring myotube formation, the medium of C2C12 myoblasts
at 	80% confluence was changed to DMEM supplemented with 2% horse
FIG. 2. PGC-1 activates the mPDK4 gene promoter through a cis-acting element within the proximal region. (A) A schematic of the reporter
construct mPDK4.Luc.2281, containing the 
2281-to-31 region of the mouse PDK4 gene promoter, is shown at the top. The graph contains
results of cotransfection studies with mPDK4.Luc.2281 in the presence (PGC-1) or absence [pcDNA(
)] of pcDNA–PGC-1 in C2C12 myotubes.
The graph represents mean (SE) relative light units (RLU) corrected for Renilla luciferase activity and normalized to the activity of
mPDK4.Luc.2281 (taken as 1.0). (B) Transient transfections performed with a 5 deletion series of mPDK4.Luc.2281. All values represent at least
three independent transfections conducted in triplicate. Asterisks indicate significant differences compared to individual reporters cotransfected
with empty vector (P  0.05). Daggers indicate significant differences in activity compared to mPDK4.Luc.2281 cotransfected with empty vector
(P  0.05).
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serum, and the cells were maintained for an additional 72 h. CV-1 cells and
C2C12 myotubes were infected at a multiplicity of infection sufficient to infect
	95% of the cells based on GFP fluorescence with minimal cell death. ERR
/

mice for primary cell culture isolation have been described elsewhere (32).
Primary mouse fibroblasts from tail tissue of ERR/ and ERR
/
 mice were
isolated and cultured as described elsewhere (20). Transient transfections were
performed by the calcium phosphate coprecipitation method (4, 11). Briefly,
reporter plasmids (4 g/ml) were cotransfected with simian virus 40 promoter-
driven Renilla luciferase (500 ng/ml), to control for transfection efficiency, and
the appropriate mammalian expression vector (500 ng/ml) or its corresponding
empty vector. For luciferase reporter assays, CV-1 cells and C2C12 myotubes
were harvested and analyzed at 48 and 72 h, respectively, using Dual-Glo (Pro-
mega) and were read in a Chameleon plate reader (Hidex, Washington, D.C.)
according to the manufacturer’s protocols. All transfection data are presented as
means  standard errors (SE) for at least three separate transfection experi-
ments done in triplicate.
RNA and protein analyses. Total cellular RNA was isolated from cells in
culture (48 h following adenovirus infection) or muscle tissue using the RNAzol
method (Tel-Test, Friendswood, TX). Northern blot analysis was performed with
QuikHyb (Stratagene) using random-primed 32P-labeled cDNA clones for
human -actin, mouse PGC-1, and PDK4. Band intensities were quantified by
phosphorimaging using a GS 525 Molecular Imager system (Bio-Rad) and nor-
malized to the expression of -actin. Real-time quantitative reverse transcrip-
tion-PCR (RT-PCR) was performed as previously described (20) and results
normalized to the expression of 36B4. The following mouse-specific primer pairs
were used: PGC-1 forward, 5-CGGAAATCATATCCAACCAG-3; PGC-1
reverse, 5-TGAGGACCGCTAGCAAGTTTG-3; PDK4 forward, 5-CCGCTG
TCCATGAAGCA-3; PDK4 reverse, 5-GCAGAAAAGCAAAGGACGTT-3;
36B4 forward, 5-GCAGACAACGTGGGCTCCAAGCAGAT-3; 36B4 re-
verse, 5-GGTCCTCCTTGGTGAACACGAAGCCC-3.
Protein extracts were resolved by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) (4 to 15% Criterion Precast; Bio-Rad) and trans-
ferred to nitrocellulose membranes (Midwest Scientific, Valley Park, MO).
Western blotting was performed using antibodies against PGC-1 (28), medium-
chain acyl coenzyme A dehydrogenase (MCAD) (24), PDK4 (a gift from R. A.
Harris, Indiana University School of Medicine), -tubulin (Molecular Probes,
Eugene, OR), PPAR, FKHR/FOXO1, and Sp1 (Santa Cruz Biotechnology,
Santa Cruz, CA). An antibody against ERR was raised in rabbits against an
N-terminal peptide corresponding to amino acids 16 to 33 of the mouse ERR
protein conjugated to keyhole limpet hemocyanin (KLH) or bovine serum
albumin (BSA). This domain is conserved among species; therefore, the antibody
recognizes rodent and human ERR isoforms. The KLH-conjugated peptide in
Freund’s adjuvant was used for the initial and second booster immunizations.
Subsequent boosts were performed with the BSA-conjugated peptide. Peptide
synthesis, conjugation, and purification by high-performance liquid chromatog-
raphy were performed through PNACL (Washington University). Peptide
immunization and serum collection were performed through Biosource
(Hopkinton, MA). The specificity of the anti-ERR antibody was determined by
the ability of this antibody to detect recombinant ERR but not ERR and by
comparison to the previously described anti-ERR antibody (47). Detection was
performed by measuring the chemiluminescent signal as assayed by SuperSignal
Ultra (Pierce, Rockford, IL).
EMSA. Electrophoretic mobility shift assays (EMSA) were performed as de-
scribed previously (6). Double-stranded complementary oligonucleotides corre-
sponding to the PGC-1-responsive element (5-gatccGGCTAGGAATGCG
TGACATTGAGATGGCTCTGGAGTTGTAAACAAGGACAAGTCTGGG
CGGGCg-3) or NRmut (5-gatccGGCTAGGAATGCGTGACATTGAGAT
GGCTCTGGAGTTGTAAACAGATCTAAGTCTGGGCGGGCg-3) (over-
hangs are shown in lowercase; mutation is underlined) of the mPDK4 promoter
were used to generate probes to assay recombinant and endogenous protein
binding in vitro. Probes were radiolabeled by a Klenow fill-in reaction. Recom-
binant proteins for ERR, PPAR, and FOXO1 were synthesized with the TNT
Quick T7-coupled translation kit (Promega). Synthesis of appropriately sized
proteins was verified in reactions incorporating [35S]methionine followed by
SDS-PAGE analysis and autoradiographic detection. Nuclear extract was iso-
lated as previously described (6). Briefly, C2C12 myotubes were infected with
Ad-GFP or Ad-PGC-1, nuclear extract was isolated 48 h following infection,
and samples were aliquoted and stored at 
80°C until use.
ChIP assays. Chromatin immunoprecipitation (ChIP) assays were performed
as previously published (21, 52). In brief, C2C12 myotubes were infected with
Ad-GFP or Ad-PGC-1. Cross-linking was performed 36 to 48 h postinfection
by incubating cells with 0.4% formaldehyde (10 min) followed by addition of
0.125 M glycine to halt cross-linking. Following cell and nuclear lysis, DNA was
sheared by sonication; enrichment for 500-bp fragments was determined by
agarose gel electrophoresis. Sheared chromatin complexes were precleared with
preimmune rabbit serum, followed by dilution of an aliquot in immunoprecipi-
tation dilution buffer and incubation overnight at 4°C with immunoglobulin G
(IgG) or a polyclonal antibody against PGC-1 or ERR (described above).
Antibody-chromatin complexes were bound with ImmunoPure immobilized pro-
tein A (Pierce), followed by isolation and purification as described previously
(20). Primers were designed to amplify a 164-bp amplicon corresponding to the
region of the mPDK4 promoter flanking the nuclear receptor (NR) response
element (nucleotides 
449 to 
285). The following mouse-specific primer pairs
were used: PDK4pro forward (5-TGATTGGCTACTGTAAAAGTCCCGC-3)
and PDK4pro reverse (5-ATCCCAGGTCGCTAGGACTTCAGG-3). Primers
amplifying the 36B4 gene (see above) were used to control for nonspecific
enrichment of DNA in the immunoprecipitation. Samples were analyzed by 2%
agarose gel electrophoresis and quantified relative to input using SYBR green
RT-PCR (Applied Biosystems, Foster City, CA).
Glucose oxidation assay. Cellular glucose oxidation rates were determined
using modifications of previously published protocols (5, 22). C2C12 myoblasts
were grown in T25 flasks and differentiated into myotubes as described above.
Forty-eight hours following infection with Ad-GFP or Ad-PGC-1, the medium
was replaced with MEM supplemented with 0.5% horse serum. Following 18 h
of reduced serum incubation, new medium was added containing 0.2 Ci/ml
[U-14C]glucose (10 mCi/mmol), 100 nM insulin, and 250 M oleate. The flasks
were immediately capped with rubber stoppers fitted with plastic wells containing
a piece of filter paper saturated with 1 M NaOH. The culture flasks were
incubated for 30 min at 37°C. Reactions were terminated with perchloric acid,
followed by overnight storage at 4°C to trap CO2. The release of 14CO2 from
glucose was measured by scintillation counting of the filter paper. Duplicate
flasks were plated for each condition. The results were normalized to total
protein (determined by the Bradford method).
RESULTS
PGC-1 induces expression of the PDK4 gene in skeletal
muscle. Physiological conditions that increase skeletal muscle
energy demands induce the expression of the transcriptional
coactivator PGC-1. As an initial step to investigate a potential
role for PGC-1 in the regulation of muscle glucose metabo-
lism via PDK4, we examined levels of mRNAs encoding
PGC-1 and PDK4 following acute exercise. For these exper-
iments, a running protocol on a motorized treadmill was em-
ployed (29). PGC-1 mRNA levels were markedly induced in
mouse gastrocnemius 12 h after two bouts of treadmill running
(Fig. 1A). The expression of PDK4 was robustly induced in
parallel with PGC-1 expression (Fig. 1A). Similar experi-
ments were conducted following cold exposure, which triggers
shivering thermogenesis in skeletal muscle and has been shown
to induce PGC-1 expression (41). The expression of PDK4
and PGC-1 genes was coordinately induced (two- to fourfold)
in muscle following 6 h of cold exposure (Fig. 1B). To assess
the temporal patterns of the physiological induction of
PGC-1 and PDK4 gene expression in muscle, a time course
experiment was performed following a single bout of exercise.
As shown in Fig. 1C, PGC-1 gene expression was markedly
induced (at 1 h postexercise) prior to the activation of PDK4
gene expression.
To determine if PGC-1 plays a direct role in the regulation
of PDK4 gene expression, we examined the effect of adenovi-
rus-mediated overexpression of PGC-1 (Ad–PGC-1) com-
pared to a control vector (Ad-GFP) in C2C12 myotubes. As
expected, we observed an increase in levels of MCAD protein,
a known PGC-1 target (51), following Ad–PGC-1 infection
(Fig. 1D). Overexpression of PGC-1 markedly activated
PDK4 mRNA and protein levels (Fig. 1D). Taken together,
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these results indicate that PGC-1 functions as an upstream
activator of PDK4 gene expression.
PGC-1 activates PDK4 gene transcription through a nu-
clear receptor binding site. To determine whether PGC-1
induces PDK4 gene expression at the transcriptional level, we
performed promoter-reporter transfections in C2C12 myotubes
in culture. For these experiments, approximately 2.3 kb of the
mPDK4 gene promoter region was cloned into a promoterless
FIG. 3. PGC-1 activates PDK4 gene transcription through a nuclear receptor binding site. (A) Species comparison of the nucleotide sequence
(sense strand is shown) of the PGC-1-activated region of the PDK4 promoter, demonstrating a high level of sequence identity between mouse,
rat, and human genes. The numbers are relative to the transcription start site (1). Shaded nucleotides indicate sequence that is not conserved.
Computer analysis revealed numerous candidate response elements, including a nuclear receptor half-site (NR1/2), an Sp1 site, and the previously
identified FOXO1 binding site (IRS) (9, 27), indicated by labels, boxes, and symbols. (B) (Top) Site-directed mutagenesis was used to abolish the
FOXO1 response element. Mutated nucleotides are lowercased. (Bottom) The mPDK4.Luc.2281 (wild type [WT]) or IRSmut.mPDK4.Luc.2281
promoter reporter was used in cotransfections in C2C12 myotubes in the presence or absence of FOXO1 (left graph) or PGC-1 (right graph).
(C) (Left) Schematic showing the mutations generated by site-directed mutagenesis of the minimal PGC-1-responsive mPDK4.Luc.371 reporter
in FOXO1 (IRSmut), NR (NRmut), or Sp1 (Sp1mut) candidate response elements (mutated nucleotides are lowercased). (Right) Cotransfection
studies using WT or mutant mPDK4 promoter reporters were performed with C2C12 myotubes. Data represent mean (SE) relative light units
(RLU) corrected for rLuc and normalized to values for the WT reporter (taken as 1.0). All transient transfection studies represent at least three
independent transfections conducted in triplicate. Asterisks indicate significant differences from individual reporters cotransfected with empty
vector (P  0.05). Daggers indicate significant differences from the wild-type reporter cotransfected with empty vector (P  0.05).
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luciferase reporter vector (mPDK4.Luc.2281). Cotransfection
of mPDK4.Luc.2281 with an expression vector for PGC-1
resulted in robust (14-fold) activation of the reporter (Fig. 2A).
To map the cis-acting region conferring the PGC-1 activa-
tion, cotransfection experiments were repeated with reporter
constructs containing serial 5 deletions of the mPDK4 pro-
moter (Fig. 2B). The PGC-1-mediated activation was lost
upon deletion of a region of the mPDK4 promoter from 
371
to
308 bp upstream of the transcription start site. In addition,




Inspection of the nucleotide sequence of the PGC-1-re-
sponsive region revealed a high degree of nucleotide identity
across species (Fig. 3A). A screen of the 63-bp DNA sequence
identified several putative transcription factor binding sites
that could support PGC-1 coactivation, including an NR half-
site, an Sp1 site, and a recently identified FOXO1 binding site
(DBE [9], or IRS3 [26]) (Fig. 3A). Interestingly, coactivation of
FOXO1 by PGC-1 has been implicated in the regulation of
hepatic gluconeogenic gene expression (39). Therefore, we
first sought to determine whether the FOXO1 response ele-
ment was necessary for the PGC-1-mediated activation. The
FOXO1 binding site within the mPDK4.Luc.2281 reporter was
abolished using a mutation that has been shown previously to
inactivate this element (9). Although the FOXO1 site mutant
was incapable of responding to FOXO1, PGC-1-mediated
activation of the mPDK4 promoter was unchanged (Fig. 3B). It
is noteworthy that the FOXO1 site mutant resulted in a 50%
reduction in basal promoter activity, indicating a PGC-1-
independent role for FOXO1.
Mutational studies were performed to examine the importance
of the putative nuclear receptor and Sp1 binding sites for PGC-1
coactivation. The nuclear receptor site was of particular interest
given that several studies have shown that PPAR and its ligands
regulate PDK4 gene expression (7, 17, 55). Although mutation of
the Sp1 response element significantly reduced the basal pro-
moter activity of the mPDK4.Luc.371 reporter, PGC-1-medi-
ated activation was maintained (Fig. 3C). In contrast, mutation
of the putative NR response element abolished activation by
PGC-1. Together, these results demonstrate that the candi-
date NR response element is required for the observed PGC-1-
mediated activation of the PDK4 gene promoter.
The orphan nuclear receptor ERR, but not PPAR, di-
rectly confers PGC-1-mediated coactivation of the mPDK4
promoter. To determine if PPAR was capable of binding to
the PGC-1-responsive NR site identified within the mPDK4
gene promoter, EMSA were performed using recombinant
PPAR and RXR, its obligate DNA binding partner. Sur-
prisingly, PPAR/RXR did not bind to this region but did
bind to a known PPAR response element from the muscle
carnitine palmitoyltransferase I gene promoter (3) (data not
shown).
The orphan nuclear receptor ERR is a recently identified
mediator of PGC-1 action (18, 46). ERR was an attractive
candidate for binding the nuclear receptor half-site within the
FIG. 4. The orphan nuclear receptor ERR binds to the PGC-1-
responsive region of the mPDK4 promoter. (A) Representative auto-
radiograph of EMSA conducted with 32P-labeled probes of the 63-bp
region of the mPDK4 promoter identified in Fig. 2B. Mutant probe
corresponds to the same nucleotide substitutions for NRmut as in
Fig. 3C. Probes were incubated with recombinant in vitro-translated
ERR (rERR) or unprogrammed reticulocyte lysate (Unprog.) as
indicated at the top. Antibody (Ab) supershift studies were performed
by incubation with an anti-ERR (lane 5) or nonspecific (n.s.) (lane 4)
Ab. Competition analysis was performed by adding a molar excess of
the unlabeled wild-type (lanes 7 and 8) or NRmut (lanes 9 and 10)
probe in increasing amounts as indicated. For lanes 11 to 13, the
32P-labeled NRmut probe was used. n.s. bands represent protein com-
plexes identified in unprogrammed reticulocyte lysate. (B) Autoradio-
graph of an EMSA using nuclear (Nuc.) extracts isolated from C2C12
myotubes incubated with the 32P-labeled wild-type probe. Four prom-
inent complexes, labeled Ia, Ib, II, and III, were observed. Complexes
were identified by antibody supershift analysis using antibodies specific
for the transcription factors indicated at the top.
FIG. 5. ERR and PGC-1 regulate the mPDK4 promoter through
the NR response element. (Top) Schematic showing the mutation
(lowercase) of the NR response element in mPDK4.Luc.2281
(NRptmut.mPDK4.Luc.2281). (Bottom) Graph depicting the results
of transient cotransfections in CV-1 cells performed with either the
mPDK4.Luc.2281 reporter (wild type [WT]) or NRptmut.mPDK4.Luc.2281
(NRptmut). Asterisks indicate significant differences from WT
mPDK4.Luc.2281 cotransfected with empty vector (P  0.05). Dag-
ger indicates a significant difference from mPDK4.Luc.2281 with
ERR (P  0.05). Double dagger indicates a significant difference
from the value obtained using NRptmut.mPDK4.Luc.2281 with empty
vector (P  0.05).
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PGC-1-responsive region of the mPDK4 promoter, because it
is capable of binding as a monomer (23) and is enriched in
slow-twitch muscle (10, 20, 47). Therefore, EMSA were re-
peated using recombinant ERR and the 63-bp region as a
probe. As shown in Fig. 4A, ERR bound the 63-bp PGC-1-
responsive region of the mPDK4 promoter (lane 3). Compe-
tition studies with unlabeled wild-type and mutated fragments
(Fig. 4A, lanes 6 to 10), as well as ERR antibody recognition
experiments (lanes 3 to 5), confirmed the specificity of the
ERR binding to the NR site. In addition, relative to the
wild-type probe, a 32P-labeled mutant probe failed to support
ERR binding (Fig. 4A, lanes 11 to 13).
To determine whether endogenous ERR bound to the
mPDK4 gene promoter, EMSA were repeated with nuclear
extracts prepared from C2C12 myotubes. Three complexes
formed with the 63-bp mPDK4 probe (Fig. 4B, complexes I to
III). Complex I, the slowest-migrating band, exhibited a dou-
blet (Ia and Ib). To identify proteins within the complexes,
antibody recognition experiments were performed using anti-
bodies to ERR, Sp1, FOXO1, and PPAR. Complex Ib was
abolished by anti-Sp1 (Fig. 4B, lane 5). Complex II was super-
shifted with anti-ERR (Fig. 4B, lane 4). Additionally, the
anti-ERR antibody disrupted complexes Ia and Ib, suggesting
a potential requirement for ERR binding in the formation of
these two complexes (Fig. 4B, lane 4). Alternatively, the latter
result could be due to the “mass action” of the supershifted
complex II. Surprisingly, FOXO1 was not identified within
any of the complexes, though the antibody was shown to
supershift recombinant FOXO1 (Fig. 4B and data not
shown). As expected, none of the complexes were recog-
nized by anti-PPAR. The identities of complexes Ia and III
are under investigation. Taken together, the EMSA studies
demonstrate that the PGC-1-mediated region of the
mPDK4 gene promoter is capable of binding both exoge-
nous and endogenous ERR.
Cotransfection studies were performed to examine the func-
tional correlate of the binding studies. For these studies, CV-1
cells were used because they are relatively deficient in ERR
and many other nuclear receptors, presenting the opportunity
to reconstitute the system with factors required for maximal
PGC-1 activation. Cotransfection of a PGC-1 expression
vector resulted in fourfold activation of mPDK4.Luc.2281,
while ERR alone resulted in a modest twofold activation
(Fig. 5). However, cotransfection of both PGC-1 and ERR
increased reporter activity nearly 10-fold, comparable to that
observed in C2C12 myotubes (compare Fig. 5 and 2A). The
FIG. 6. PGC-1 induces expression of the endogenous ERR gene
in skeletal muscle cells.(A) Representative autoradiograph of Western
blot analysis performed on nuclear extracts isolated from C2C12 myo-
tubes following infection with Ad-GFP or Ad–PGC-1 as indicated at
the top. The antibodies used are given on the left. Arrows on the right
indicate specific (PGC-1 and ERR) bands. (B) EMSA study per-
formed with nuclear extracts isolated from C2C12 myotubes following
infection with Ad-GFP (lane 2) or Ad–PGC-1 (lanes 3 to 8) and the
wild-type probe described in the legend to Fig. 4. Complexes II and Ib
were identified by antibody (Ab) supershift analysis using Abs specific
for ERR and Sp1, respectively (lanes 5 and 6). n.s., nonspecific.
(C) Chromatin immunoprecipitation assays performed on C2C12 myo-
tubes following infection by Ad–PGC-1. Formaldehyde cross-linked
protein-DNA complexes were isolated. Sheared protein-DNA com-
plexes were immunoprecipitated with a nonspecific antibody (IgG),
anti-ERR, or anti-PGC-1. Isolated fragments were amplified by
PCR to detect the enrichment of amplicons corresponding to a 190-bp
region of the 36B4 gene (negative control) or a 164-bp region encom-
passing the NR response element of the mPDK4 gene promoter. (Top)
Results of agarose gel analysis of a representative trial showing relative
band intensities. Input represents 2% of the total chromatin used in
the immunoprecipitation reactions. (Bottom) Graphs contain mean
values as determined by SYBR green quantification of three indepen-
dent chromatin isolations and immunoprecipitations (arbitrary units
SE) normalized to the value for the IgG control (taken as 1.0). Aster-
isks indicate significant differences from the IgG control (P  0.05).
FIG. 7. ERR is required for PGC-1-mediated activation of
PDK4 gene transcription. Primary fibroblasts isolated from wild-type
or ERR
/
 mice were cotransfected with mPDK4.Luc.2281 and an
expression vector for PGC-1 or ERR, or both. Asterisks indicate
significant differences from wild-type mPDK4.Luc.2281 cotransfected
with empty vector (P  0.05). Dagger indicates a significant difference
from mPDK4.Luc.2281 cotransfected with ERR (P  0.05).
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PGC-1/ERR response was dependent on the NR response
element, because the mutant construct did not exhibit activa-
tion by either factor alone, showing only a very modest increase
with the combination (Fig. 5). These data indicate that ERR
is sufficient to confer the PGC-1-mediated transcriptional
activation.
PGC-1 increases ERR expression and PDK4 promoter
binding in skeletal myotubes. PGC-1 has been shown to
directly coactivate ERR (18). In addition, in certain cell con-
texts, PGC-1 activates ERR gene expression (27, 46). To
determine whether the activation of PDK4 expression by
PGC-1 involved simultaneous activation of ERR expres-
sion, endogenous ERR protein expression levels were as-
sessed following adenovirus-mediated overexpression of
PGC-1 in C2C12 myotubes. ERR protein levels were mark-
edly increased in Ad–PGC-1-infected C2C12 myotubes, while
the expression of PPAR, FOXO1, and Sp1 was unchanged
(Fig. 6A). Consistent with upregulation of ERR expression,
EMSA performed with nuclear extracts prepared from C2C12
myotubes following Ad–PGC-1 infection revealed that the
intensity of complex II on the PGC-1-responsive region of the
PDK4 promoter was markedly increased, accompanied by a
modest increase in complex III (Fig. 6B, lanes 2 and 3). Ad-
dition of an ERR-specific antibody again confirmed the iden-
tity of complex II (Fig. 6B, lane 5). As a separate control,
EMSA using extracts from Ad-PPAR-infected cells did not
show any changes in complex intensity compared to the control
(data not shown).
The transfection and gel shift studies strongly suggested that
a cooperative interaction between ERR and PGC-1 at the
NR half-site leads to activation of PDK4 gene transcription. To
determine whether these factors simultaneously occupy the
endogenous promoter site in cells, ChIP assays were per-
formed on chromatin isolated from Ad–PGC-1-infected
C2C12 myotubes. Neither the anti-ERR nor the anti-PGC-1
antibody enriched for the promoter region over a nonspecific
IgG control following infection with the Ad-GFP backbone
(data not shown). However, following Ad–PGC-1 infection,
antibodies specific to ERR or PGC-1 significantly enriched
for the endogenous PDK4 promoter region, four- to fivefold
over the IgG control (Fig. 6C). These results confirm that both
PGC-1 and ERR occupy the PGC-1-responsive region of
the mPDK4 promoter in skeletal myotubes and that PGC-1
enriches the level of binding, likely via increasing ERR gene
expression.
ERR is required for PGC-1-mediated activation of the
PDK4 gene promoter. The data shown above support the con-
clusion that both ERR and PGC-1 are capable of activating
PDK4 gene transcription. To determine if ERR is actually
required for PGC-1-mediated activation, we assessed the
ability of PGC-1 to activate the PDK4 promoter in ERR-
null cells. For these experiments, fibroblasts were isolated from
ERR-null (ERR
/
) (32) and wild-type (ERR/) mice.
Cotransfection of a PGC-1 or ERR expression vector with
the mPDK.Luc.2281 reporter in wild-type cultured primary
fibroblasts led to 3.5-fold and 2.5-fold increases in reporter
activity, respectively; while addition of both PGC-1 and
ERR increased reporter activity 6-fold (Fig. 7). In ERR
/

fibroblasts, cotransfection of either a PGC-1 or an ERR
expression vector alone failed to induce mPDK4.Luc.2281 re-
porter activity (Fig. 7). However, cotransfection of both ERR
and PGC-1 rescued PGC-1-mediated activation in ERR
/

fibroblasts, resulting in a nearly fivefold induction (Fig. 7).
These results demonstrate that ERR is required for PGC-1-
mediated activation of the mPDK4 gene promoter.
PGC-1 decreases glucose oxidation in C2C12 myotubes. To
determine the functional relevance of PGC-1-mediated acti-
vation of PDK4 expression, cellular glucose oxidation rates
were determined in the presence and absence of overexpressed
PGC-1. For these experiments, glucose oxidation was mea-
sured as the release of 14CO2 from [U-
14C]glucose in C2C12
myotubes. Mean glucose oxidation rates were markedly re-
duced (by approximately 75%) in C2C12 myotubes following
infection with Ad–PGC-1 compared to Ad-GFP-infected
controls (Fig. 8).
DISCUSSION
Skeletal muscle is capable of rapid adjustments in ATP
production and fuel preference in accordance with diverse
physiological conditions. In order to match energy require-
ments with activity demands, muscle substrate utilization
pathways must be tightly controlled. During intense bouts of
exercise, the majority of the muscles’ energy demands are
met by glucose. Following exercise, muscle glucose is spared
through a shift toward mitochondrial fatty acid oxidation so
that glycogen levels may be quickly replenished. The molec-
ular basis for the metabolic plasticity of muscle involves
rapid changes in the activity of enzymes via allosteric control
and posttranslational modifications as well as chronic
changes through the regulation of numerous genes control-
ling mitochondrial content and substrate preference. Delin-
eation of the mechanisms involved in the gene expression
changes is critical for the understanding of the molecular
pathogenesis of disease states where substrate utilization is
chronically deranged, such as heart failure, obesity, and
diabetes. In this report, we identify PDK4, an important
negative regulator of muscle glucose oxidation, as a new
target of PGC-1-mediated regulation.
FIG. 8. PGC-1 decreases glucose oxidation in C2C12 myotubes.
The graph represents mean (SE) [U-14C]glucose oxidation rates in
C2C12 myotubes infected with Ad–PGC-1 or Ad-GFP (control). Re-
sults are based on three independent experiments performed in trip-
licate. Asterisk indicates a significant difference from the GFP-infected
control (P  0.001).
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The inducible transcriptional coactivator PGC-1 has been
identified as a key regulator of multiple ATP-generating path-
ways in striated muscle through its regulatory influence on
genes involved in mitochondrial biogenesis, respiration, oxida-
tive phosphorylation, and fatty acid oxidation (reviewed in
references 25 and 40). However, little is known about the
potential role of PGC-1 in the control of muscle glucose
utilization pathways. The pioneering studies of Randle et al.
demonstrated that glucose oxidation is decreased coincident
with increased fatty acid oxidation in heart muscle (42). This
inhibition of glucose oxidation occurs at the level of the pyru-
vate dehydrogenase complex, among other enzymes, via allo-
steric effects of the products of fatty acid oxidation and through
changes in the cellular redox state. Our results indicate that
PGC-1 may also contribute to this counter-regulatory effect
at the level of gene expression in skeletal muscle through
modulation of PDK4, a negative regulator of the PDC com-
plex. Recent reports have shown a role for PGC-1 in glucose
replenishment in the liver through the regulation of gluconeo-
genic enzyme genes (14, 39, 57). The regulatory mechanism
described by the current study, in which PGC-1 increases
muscle PDK4 expression, may serve to replenish glycogen lev-
els in muscle through a different mechanism, by reducing glu-
cose oxidation. Interestingly, PGC-1 has also been shown to
activate the expression of the insulin-sensitive glucose trans-
porter GLUT4 in muscle (33), which would also serve to in-
crease glycogen stores in the context of increased PDK4 levels.
Our results identify the orphan nuclear receptor ERR as
the mediator of PGC-1-induced activation of mPDK4 gene
expression. Recently, ERR was identified as a critical tran-
scriptional regulator of cellular energy metabolism. The activ-
ity of ERR appears to be highly dependent on PGC-1
(18, 45). PGC-1-mediated coactivation of some ERR tar-
gets, such as MCAD (47), ATP synthase , and cytochrome c
(45), is conferred directly by ERR binding to elements within
the promoter regions of these genes. In addition, we recently
demonstrated that ERR is capable of regulating gene expres-
sion indirectly by activating the transcription of PPAR (20).
ERR has also been shown to cooperate with the transcription
factors NRF-1 and NRF-2 to activate the expression of genes
involved in mitochondrial respiratory function (45). The
“PGC-1/ERR circuit” was further defined when it was
shown that PGC-1 could induce ERR expression through
ERR by an autoregulatory feed-forward mechanism (27).
Thus, ERR serves a central function in the PGC-1 gene
regulatory cascade. The current study expands the list of
ERR target genes to include PDK4. Our results show that
PGC-1 not only directly coactivates ERR but also activates
its expression through the autoregulatory loop described pre-
viously.
Previous work has implicated the nuclear receptor PPAR,
a known PGC-1 target factor, in the regulation of PDK4 gene
expression. Specifically, the PPAR selective ligand compound
WY-14,643 induces PDK4 gene expression (17), and this re-
sponse is lost in the hearts and kidneys of PPAR-null mice
(55). Somewhat surprisingly, our results demonstrate that
PGC-1-mediated activation of PDK4 gene expression occurs
independently of PPAR. It should be noted that a direct
mechanism for PPAR-mediated activation of PDK4 gene ex-
pression has not been shown. However, the current study
does not rule out an indirect role for PPAR in regulating
PDK4 gene expression or direct PPAR-mediated activa-
tion through elements outside of the promoter region ex-
amined in our study.
The transcription factor FOXO1 has been shown to function
with PGC-1 in the regulation of liver gluconeogenesis (39).
Recent studies have shown that the GR in cooperation with
FOXO1 activates transcription of the human PDK4 gene. This
transcriptional regulatory effect is mediated by a complex
mechanism involving the interaction of a single GR response
element and three FOXO1 response elements within the
hPDK4 gene promoter region (26). This region is not con-
served in the mouse PDK4 promoter. As with PPAR, we were
also surprised to find that the FOXO1 response element in the
proximal mPDK4 promoter was dispensable for the observed
PGC-1 effect. To our knowledge, the influence of PGC-1 on
the human PDK4 gene promoter has not been studied. How-
ever, inspection of the human PDK4 promoter sequence indi-
cates that a PGC-1/ERR-responsive region may be con-
served in the human promoter. Although the ERR response
element we identified in the mPDK4 gene is not spatially
conserved in the hPDK4 promoter, a candidate monomeric
ERR response element (AAGGACA; bp 
823 to 
817) does
exist, overlapping the previously identified GR response ele-
FIG. 9. Proposed mechanism for the regulation of muscle glucose metabolism by PGC-1/ERR. Increased energy demands related to
physiological stress (e.g., exercise) result in the induction of muscle PGC-1 gene expression, which in turn induces ERR gene expression. ERR
then binds to the PDK4 gene promoter, where PGC-1 directly coactivates ERR to induce PDK4 gene expression. PDK4 has known roles in the
negative regulation of the PDC, resulting in decreased glucose oxidation coincident with increased mitochondrial fatty acid oxidation driven by
PGC-1.
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ment in the hPDK4 gene (26). Interestingly, a previous report
describes the modulation of GR activity by ERR isoforms (50).
It is tempting to speculate that ERR and GR regulatory
pathways converge on the human PDK4 gene.
In summary, our findings, together with the known regula-
tory effects of PGC-1 on cellular energy metabolism, suggest
a mechanism by which PGC-1 is able to suppress muscle
glucose oxidation while increasing the expression of genes in-
volved in mitochondrial fatty acid oxidation (Fig. 9). Energy
demands placed on skeletal muscle result in increased utiliza-
tion of fatty acids, mediated in part through the activating
effects of PGC-1 on the expression of genes involved in
cellular fatty acid uptake and oxidation. Induction of PGC-1
activates ERR expression, leading to occupation of the
PGC-1/ERR complex on the PDK4 promoter. The resultant
increased expression of PDK4 leads to phosphorylation and
inactivation of the PDC, which catalyzes the rate-limiting step
of glucose oxidation (48). This model is consistent with the
response to endurance training, a known stimulus for increas-
ing fatty acid oxidative capacity and mitochondrial biogenesis.
Collectively, these findings expand the role of the PGC-1/
ERR complex to a regulator of muscle substrate selection,
leading to a better understanding of transcriptional mecha-
nisms involved in the maintenance of energy homeostasis.
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